Sana Biotechnology (SANA) Cash & Equivalents (2020 - 2026)
Sana Biotechnology's Cash & Equivalents came in at $57.07 million for Q2 2026, down 19.9% from $71.27 million a year earlier and down 31.9% from the prior quarter.
Powered by 
Analysis
Sana Biotechnology (SANA) Cash & Equivalents (2020 - 2026) Analysis & Trends
At the end of FY2025, Sana Biotechnology's Cash & Equivalents was $71.87 million, down 43.7% from FY2024.
- Cash & Equivalents has declined in each of the last four years, with a five-year compound annual growth rate of -10.5% (FY2020 to FY2025).
- Going back by year, Cash & Equivalents was $127.57 million in FY2024 (-4.5%), $133.52 million in FY2023 (-24.5%), $176.77 million in FY2022 (-30.1%) and $253.03 million in FY2021 (+102.7%).
- The Q2 2026 figure represents the lowest quarterly Cash & Equivalents in data going back to Q4 2020.
- Year-over-year, Cash & Equivalents has declined for nine consecutive quarters, with an average decline of 27.1% over the last eight quarters.
- The fastest year-over-year change in Cash & Equivalents over five years came in Q4 2021 (growth of 102.7%), and the weakest in Q1 2022 (a decline of 74.9%).
- Business Quant data shows SANA's Cash & Equivalents at $83.8 million (Q1 2026), $71.87 million (Q4 2025) and $103.36 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 976.00 Mn |
| 10 | Sana Biotechnology | 864.99 Mn | 864.99 Mn | - | 57.07 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 57.07 Mn |
| Mar 31, 2026 | 83.80 Mn |
| Dec 31, 2025 | 71.87 Mn |
| Sep 30, 2025 | 103.36 Mn |
| Jun 30, 2025 | 71.27 Mn |
| Mar 31, 2025 | 96.13 Mn |
| Dec 31, 2024 | 127.57 Mn |
| Sep 30, 2024 | 127.00 Mn |
| Jun 30, 2024 | 134.96 Mn |
| Mar 31, 2024 | 177.05 Mn |
| Dec 31, 2023 | 133.52 Mn |
| Sep 30, 2023 | 168.45 Mn |
| Jun 30, 2023 | 173.79 Mn |
| Mar 31, 2023 | 160.46 Mn |
| Dec 31, 2022 | 176.77 Mn |
| Sep 30, 2022 | 163.34 Mn |
| Jun 30, 2022 | 194.66 Mn |
| Mar 31, 2022 | 188.52 Mn |
| Dec 31, 2021 | 253.03 Mn |
| Sep 30, 2021 | 433.67 Mn |
API Access
Sana Biotechnology Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SANA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "SANA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=SANA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();